Literature DB >> 25346337

GAGE12 mediates human gastric carcinoma growth and metastasis.

Eun Kyung Lee1, Kyung-A Song, Ji-Hye Chae, Kyoung-Mee Kim, Seok-Hyung Kim, Myung-Soo Kang.   

Abstract

The spontaneous metastasis from human gastric carcinoma (GC) remains poorly reproduced in animal models. Here, we established an experimental mouse model in which GC progressively developed in the orthotopic stomach wall and metastasized to multiple organs; the tumors colonized in the ovary exhibited typical characteristics of Krukenberg tumor. The expression of mesenchymal markers was low in primary tumors and high in those in intravasating and extravasating veins. However, the expression of epithelial markers did not differ, indicating that the acquisition of mesenchymal markers without a concordant loss of typical epithelial markers was associated with metastasis. We identified 35 differentially expressed genes (DEGs) in GC cells metastasized to ovary, among which overexpression of GAGE12 family genes, the top-ranked DEGs, were validated. In addition, knockdown of the GAGE12 gene family affected transcription of many of the aforementioned 35 DEGs and inhibited trans-well migration, tumor sphere formation in vitro and tumor growth in vivo. In accordance, GAGE12 overexpression augmented migration, tumor sphere formation and sustained in vivo tumor growth. Taken together, the GAGE12 gene family promotes GC growth and metastasis by modulating the expression of GC metastasis-related genes.
© 2014 UICC.

Entities:  

Keywords:  EMT; GAGE; Krukenberg; MET; animal model; gastric carcinoma; metastasis; orthotopic; ovary; stomach

Mesh:

Substances:

Year:  2014        PMID: 25346337     DOI: 10.1002/ijc.29286

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Oncogenic cancer/testis antigens: prime candidates for immunotherapy.

Authors:  Morten F Gjerstorff; Mads H Andersen; Henrik J Ditzel
Journal:  Oncotarget       Date:  2015-06-30

2.  The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.

Authors:  Erin A Maine; Jill M Westcott; Amanda M Prechtl; Tuyen T Dang; Angelique W Whitehurst; Gray W Pearson
Journal:  Oncotarget       Date:  2016-03-22

3.  A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.

Authors:  Jihyun Park; Sun Young Kim; Ha-Jung Kim; Kyoung-Mee Kim; Eun Young Choi; Myung-Soo Kang
Journal:  Oncotarget       Date:  2016-05-10

4.  Evaluation of the Response of HNSCC Cell Lines to γ-Rays and 12C Ions: Can Radioresistant Tumors Be Identified and Selected for 12C Ion Radiotherapy?

Authors:  Lianghao Ding; Brock J Sishc; Elizabeth Polsdofer; John S Yordy; Angelica Facoetti; Mario Ciocca; Debabrata Saha; Arnold Pompos; Anthony J Davis; Michael D Story
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

5.  miR-28-5p's Targeting of GAGE12I Inhibits Proliferation, Migration, and Invasion of Gastric Cancer in Vitro.

Authors:  Ruizhe Xu; Qi Guo; Peifeng Zhao; Haiyan Lu; Bo Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

6.  FFPE samples from cavitational ultrasonic surgical aspirates are suitable for RNA profiling of gliomas.

Authors:  Cristina Alenda; Estefanía Rojas; Luis M Valor
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

7.  The role of GAGE cancer/testis antigen in metastasis: the jury is still out.

Authors:  Morten Frier Gjerstorff; Mikkel Green Terp; Malene Bredahl Hansen; Henrik Jørn Ditzel
Journal:  BMC Cancer       Date:  2016-01-08       Impact factor: 4.430

8.  Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing.

Authors:  Qin Yang; Cancan Zhang; Yuan Ren; Huan Yi; Tianjiao Luo; Fangliang Xing; Xuefeng Bai; Lining Cui; Linyan Zhu; Jun Ouyang; Pengcheng Jiang; Weirong Fan; Jianping Qiu; Fengmian Wang; Xin Xing; Zhigang Zhang; Xueli Zhang; Rong Zhang
Journal:  Neoplasia       Date:  2020-07-07       Impact factor: 5.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.